Offer for Cambridge Antibody

AstraZeneca PLC
22 August 2006


                AstraZeneca UK Limited Completes Acquisition of
                    Cambridge Antibody Technology Group plc

                   Compulsory Acquisition Procedure Completed

                         Subsequent Offer Period Closed



AstraZeneca today announced that it has completed the compulsory acquisition
procedure under the Interim Regulations and now owns 100 percent of the issued
share capital of CAT.

The Subsequent Offer Period has now ended and the Offer is closed for further
acceptance.

Defined terms used in this announcement have the same meanings as in the Offer
Document dated 23 May 2006.



22 August 2006

Enquiries:

AstraZeneca

Media Enquiries:
Steve Brown (London)                           [phone]
Edel McCaffrey (London)                        [phone]
Staffan Ternby (Sweden)                        [phone]

Analyst/Investor Enquiries:
Jonathan Hunt (London)                         [phone]
Jorgen Winroth (US)                            [phone]



-Ends-


                      This information is provided by RNS
            The company news service from the London Stock Exchange